Cargando…

Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers

SIMPLE SUMMARY: Although cervical cancer is mainly caused by infection with human papillomavirus (HPV), some cervical cancers test negative for HPV. As these HPV-negative cervical cancers are often diagnosed at an advanced stage and have a poor prognosis, it is important to understand their molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Hiroshi, Shiraishi, Kouya, Kato, Tomoyasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699825/
https://www.ncbi.nlm.nih.gov/pubmed/34944973
http://dx.doi.org/10.3390/cancers13246351
_version_ 1784620607225200640
author Yoshida, Hiroshi
Shiraishi, Kouya
Kato, Tomoyasu
author_facet Yoshida, Hiroshi
Shiraishi, Kouya
Kato, Tomoyasu
author_sort Yoshida, Hiroshi
collection PubMed
description SIMPLE SUMMARY: Although cervical cancer is mainly caused by infection with human papillomavirus (HPV), some cervical cancers test negative for HPV. As these HPV-negative cervical cancers are often diagnosed at an advanced stage and have a poor prognosis, it is important to understand their molecular pathology. Here, we provide an overview of the potential causes of false-negative HPV tests, as well as the histology, genetic profile, and pathogenesis of HPV-negative cancers. ABSTRACT: Cervical cancer is the fourth most common cancer in women worldwide and is predominantly caused by infection with human papillomavirus (HPV). However, a small subset of cervical cancers tests negative for HPV, including true HPV-independent cancers and false-negative cases. True HPV-negative cancers appear to be more prevalent in certain pathological adenocarcinoma subtypes, such as gastric- and clear-cell-type adenocarcinomas. Moreover, HPV-negative cervical cancers have proven to be a biologically distinct tumor subset that follows a different pathogenetic pathway to HPV-associated cervical cancers. HPV-negative cervical cancers are often diagnosed at an advanced stage with a poor prognosis and are expected to persist in the post-HPV vaccination era; therefore, it is important to understand HPV-negative cancers. In this review, we provide a concise overview of the molecular pathology of HPV-negative cervical cancers, with a focus on their definitions, the potential causes of false-negative HPV tests, and the histology, genetic profiles, and pathogenesis of HPV-negative cancers.
format Online
Article
Text
id pubmed-8699825
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86998252021-12-24 Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers Yoshida, Hiroshi Shiraishi, Kouya Kato, Tomoyasu Cancers (Basel) Review SIMPLE SUMMARY: Although cervical cancer is mainly caused by infection with human papillomavirus (HPV), some cervical cancers test negative for HPV. As these HPV-negative cervical cancers are often diagnosed at an advanced stage and have a poor prognosis, it is important to understand their molecular pathology. Here, we provide an overview of the potential causes of false-negative HPV tests, as well as the histology, genetic profile, and pathogenesis of HPV-negative cancers. ABSTRACT: Cervical cancer is the fourth most common cancer in women worldwide and is predominantly caused by infection with human papillomavirus (HPV). However, a small subset of cervical cancers tests negative for HPV, including true HPV-independent cancers and false-negative cases. True HPV-negative cancers appear to be more prevalent in certain pathological adenocarcinoma subtypes, such as gastric- and clear-cell-type adenocarcinomas. Moreover, HPV-negative cervical cancers have proven to be a biologically distinct tumor subset that follows a different pathogenetic pathway to HPV-associated cervical cancers. HPV-negative cervical cancers are often diagnosed at an advanced stage with a poor prognosis and are expected to persist in the post-HPV vaccination era; therefore, it is important to understand HPV-negative cancers. In this review, we provide a concise overview of the molecular pathology of HPV-negative cervical cancers, with a focus on their definitions, the potential causes of false-negative HPV tests, and the histology, genetic profiles, and pathogenesis of HPV-negative cancers. MDPI 2021-12-17 /pmc/articles/PMC8699825/ /pubmed/34944973 http://dx.doi.org/10.3390/cancers13246351 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Yoshida, Hiroshi
Shiraishi, Kouya
Kato, Tomoyasu
Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers
title Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers
title_full Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers
title_fullStr Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers
title_full_unstemmed Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers
title_short Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers
title_sort molecular pathology of human papilloma virus-negative cervical cancers
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699825/
https://www.ncbi.nlm.nih.gov/pubmed/34944973
http://dx.doi.org/10.3390/cancers13246351
work_keys_str_mv AT yoshidahiroshi molecularpathologyofhumanpapillomavirusnegativecervicalcancers
AT shiraishikouya molecularpathologyofhumanpapillomavirusnegativecervicalcancers
AT katotomoyasu molecularpathologyofhumanpapillomavirusnegativecervicalcancers